Dupixent Market: Transforming Specialty Pharmaceuticals with Advanced Immunotherapy Solutions
The pharmaceutical industry is witnessing a major transformation with the growing adoption of targeted biologic therapies for chronic inflammatory and immune-mediated diseases. Advances in immunology research have enabled the development of highly specific treatments that address the underlying mechanisms of disease rather than only managing symptoms. Among these innovations, monoclonal...
0 Comments 0 Shares 33 Views 0 Reviews